Milestone Scientific Inc. (AMEX: MLSS) Stock Competitors & Peer Comparison
See MLSS's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MLSS and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MLSS | $0.39 | -2.94% | 34.5M | -6.50 | -$0.06 | N/A |
| BDX | $156.36 | +2.22% | 56.6B | 11.62 | $13.45 | +2.39% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.39% |
| MDLN | $38.75 | +2.98% | 32.8B | 45.06 | $0.86 | N/A |
| WST | $328.20 | -7.67% | 23.2B | 41.19 | $7.97 | +0.26% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| COO | $70.31 | +0.11% | 13.7B | 15.42 | $4.56 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.39% |
| BAX | $22.40 | +3.37% | 11.6B | 10.77 | $2.08 | +0.89% |
| ATR | $132.36 | +2.61% | 8.4B | 23.13 | $5.72 | +1.43% |
Stock Comparison
Becton, Dickinson and Company (NYSE: BDX)
MLSS vs BDX Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, BDX has a market cap of 56.6B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while BDX trades at $156.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas BDX's P/E ratio is 11.62. In terms of profitability, MLSS's ROE is -1.66%, compared to BDX's ROE of +0.05%. Regarding short-term risk, MLSS is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
MLSS vs BDXA Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas BDXA's P/E ratio is 45.70. In terms of profitability, MLSS's ROE is -1.66%, compared to BDXA's ROE of +0.05%. Regarding short-term risk, MLSS is more volatile compared to BDXA. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
MLSS vs MDLN Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, MDLN has a market cap of 32.8B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while MDLN trades at $38.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas MDLN's P/E ratio is 45.06. In terms of profitability, MLSS's ROE is -1.66%, compared to MDLN's ROE of +0.07%. Regarding short-term risk, MLSS is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
MLSS vs WST Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, WST has a market cap of 23.2B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while WST trades at $328.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas WST's P/E ratio is 41.19. In terms of profitability, MLSS's ROE is -1.66%, compared to WST's ROE of +0.19%. Regarding short-term risk, MLSS is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
MLSS vs HOLX Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas HOLX's P/E ratio is 31.54. In terms of profitability, MLSS's ROE is -1.66%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, MLSS is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check HOLX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
MLSS vs COO Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, COO has a market cap of 13.7B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while COO trades at $70.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas COO's P/E ratio is 15.42. In terms of profitability, MLSS's ROE is -1.66%, compared to COO's ROE of +0.03%. Regarding short-term risk, MLSS is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check COO's competition here
Becton, Dickinson and Company (NYSE: BDXB)
MLSS vs BDXB Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas BDXB's P/E ratio is 7.60. In terms of profitability, MLSS's ROE is -1.66%, compared to BDXB's ROE of +0.05%. Regarding short-term risk, MLSS is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
MLSS vs BAX Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, BAX has a market cap of 11.6B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while BAX trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas BAX's P/E ratio is 10.77. In terms of profitability, MLSS's ROE is -1.66%, compared to BAX's ROE of -0.16%. Regarding short-term risk, MLSS is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check BAX's competition here
AptarGroup, Inc. (NYSE: ATR)
MLSS vs ATR Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while ATR trades at $132.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas ATR's P/E ratio is 23.13. In terms of profitability, MLSS's ROE is -1.66%, compared to ATR's ROE of +0.14%. Regarding short-term risk, MLSS is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check ATR's competition here
Avantor, Inc. (NYSE: AVTR)
MLSS vs AVTR Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, AVTR has a market cap of 7.8B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while AVTR trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas AVTR's P/E ratio is 13.46. In terms of profitability, MLSS's ROE is -1.66%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, MLSS is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check AVTR's competition here
Repligen Corporation (NASDAQ: RGEN)
MLSS vs RGEN Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, RGEN has a market cap of 7.4B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while RGEN trades at $131.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas RGEN's P/E ratio is 73.31. In terms of profitability, MLSS's ROE is -1.66%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, MLSS is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check RGEN's competition here
Teleflex Incorporated (NYSE: TFX)
MLSS vs TFX Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, TFX has a market cap of 5.8B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while TFX trades at $132.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas TFX's P/E ratio is 12.32. In terms of profitability, MLSS's ROE is -1.66%, compared to TFX's ROE of -0.28%. Regarding short-term risk, MLSS is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check TFX's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
MLSS vs BLCO Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, BLCO has a market cap of 5.8B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while BLCO trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas BLCO's P/E ratio is 24.88. In terms of profitability, MLSS's ROE is -1.66%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, MLSS is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
MLSS vs STVN Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, STVN has a market cap of 5.4B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while STVN trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas STVN's P/E ratio is 31.81. In terms of profitability, MLSS's ROE is -1.66%, compared to STVN's ROE of +0.10%. Regarding short-term risk, MLSS is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
MLSS vs MMSI Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, MMSI has a market cap of 4.4B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while MMSI trades at $74.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas MMSI's P/E ratio is 19.01. In terms of profitability, MLSS's ROE is -1.66%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, MLSS is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
MLSS vs ICUI Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while ICUI trades at $157.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas ICUI's P/E ratio is 19.66. In terms of profitability, MLSS's ROE is -1.66%, compared to ICUI's ROE of +0.02%. Regarding short-term risk, MLSS is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check ICUI's competition here
Haemonetics Corporation (NYSE: HAE)
MLSS vs HAE Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while HAE trades at $78.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas HAE's P/E ratio is 15.86. In terms of profitability, MLSS's ROE is -1.66%, compared to HAE's ROE of +0.11%. Regarding short-term risk, MLSS is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check HAE's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
MLSS vs XRAY Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, XRAY has a market cap of 2.6B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while XRAY trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas XRAY's P/E ratio is 9.04. In terms of profitability, MLSS's ROE is -1.66%, compared to XRAY's ROE of -0.41%. Regarding short-term risk, MLSS is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
MLSS vs LMAT Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, LMAT has a market cap of 2.2B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while LMAT trades at $95.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas LMAT's P/E ratio is 37.05. In terms of profitability, MLSS's ROE is -1.66%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, MLSS is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check LMAT's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
MLSS vs PLSE Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, PLSE has a market cap of 2.1B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while PLSE trades at $30.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas PLSE's P/E ratio is -27.48. In terms of profitability, MLSS's ROE is -1.66%, compared to PLSE's ROE of -0.87%. Regarding short-term risk, MLSS is more volatile compared to PLSE. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
MLSS vs ATRC Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, ATRC has a market cap of 1.8B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while ATRC trades at $35.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas ATRC's P/E ratio is 1088.20. In terms of profitability, MLSS's ROE is -1.66%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, MLSS is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check ATRC's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
MLSS vs BLFS Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, BLFS has a market cap of 1.5B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while BLFS trades at $29.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas BLFS's P/E ratio is -141.85. In terms of profitability, MLSS's ROE is -1.66%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, MLSS is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
MLSS vs AZTA Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, AZTA has a market cap of 1.3B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while AZTA trades at $27.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas AZTA's P/E ratio is 60.82. In terms of profitability, MLSS's ROE is -1.66%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, MLSS is more volatile compared to AZTA. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
MLSS vs KMTS Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, KMTS has a market cap of 1.2B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while KMTS trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas KMTS's P/E ratio is -8.92. In terms of profitability, MLSS's ROE is -1.66%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, MLSS is more volatile compared to KMTS. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
MLSS vs STAA Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while STAA trades at $23.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas STAA's P/E ratio is 41.02. In terms of profitability, MLSS's ROE is -1.66%, compared to STAA's ROE of -0.06%. Regarding short-term risk, MLSS is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
MLSS vs QDEL Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, QDEL has a market cap of 1.1B. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while QDEL trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas QDEL's P/E ratio is 11.98. In terms of profitability, MLSS's ROE is -1.66%, compared to QDEL's ROE of -0.56%. Regarding short-term risk, MLSS is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
MLSS vs ATRI Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas ATRI's P/E ratio is 64.50. In terms of profitability, MLSS's ROE is -1.66%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, MLSS is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
MLSS vs ANGO Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, ANGO has a market cap of 561.7M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while ANGO trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas ANGO's P/E ratio is -34.85. In terms of profitability, MLSS's ROE is -1.66%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, MLSS is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
MLSS vs NNNN Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, NNNN has a market cap of 441.5M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while NNNN trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas NNNN's P/E ratio is 145.38. In terms of profitability, MLSS's ROE is -1.66%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, MLSS is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
MLSS vs OSUR Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, OSUR has a market cap of 273.3M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while OSUR trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas OSUR's P/E ratio is -4.78. In terms of profitability, MLSS's ROE is -1.66%, compared to OSUR's ROE of -0.21%. Regarding short-term risk, MLSS is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check OSUR's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
MLSS vs SMTI Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, SMTI has a market cap of 234.2M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while SMTI trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas SMTI's P/E ratio is -426.00. In terms of profitability, MLSS's ROE is -1.66%, compared to SMTI's ROE of -2.46%. Regarding short-term risk, MLSS is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check SMTI's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
MLSS vs UTMD Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, UTMD has a market cap of 213.8M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while UTMD trades at $67.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas UTMD's P/E ratio is 19.86. In terms of profitability, MLSS's ROE is -1.66%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, MLSS is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check UTMD's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
MLSS vs INFU Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, INFU has a market cap of 183.9M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while INFU trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas INFU's P/E ratio is 23.97. In terms of profitability, MLSS's ROE is -1.66%, compared to INFU's ROE of +0.14%. Regarding short-term risk, MLSS is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check INFU's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
MLSS vs KRMD Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, KRMD has a market cap of 175.9M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while KRMD trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas KRMD's P/E ratio is -95.75. In terms of profitability, MLSS's ROE is -1.66%, compared to KRMD's ROE of -0.14%. Regarding short-term risk, MLSS is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check KRMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
MLSS vs PDEX Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, PDEX has a market cap of 175.4M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while PDEX trades at $54.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas PDEX's P/E ratio is 19.34. In terms of profitability, MLSS's ROE is -1.66%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, MLSS is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check PDEX's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
MLSS vs MBOT Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, MBOT has a market cap of 77.9M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while MBOT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas MBOT's P/E ratio is -6.58. In terms of profitability, MLSS's ROE is -1.66%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, MLSS is more volatile compared to MBOT. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
MLSS vs AKYA Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas AKYA's P/E ratio is -1.34. In terms of profitability, MLSS's ROE is -1.66%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, MLSS is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
MLSS vs STSS Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, STSS has a market cap of 58.4M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while STSS trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas STSS's P/E ratio is -0.02. In terms of profitability, MLSS's ROE is -1.66%, compared to STSS's ROE of -1.66%. Regarding short-term risk, MLSS is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check STSS's competition here
Daxor Corporation (NASDAQ: DXR)
MLSS vs DXR Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, DXR has a market cap of 52.7M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while DXR trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas DXR's P/E ratio is 27.33. In terms of profitability, MLSS's ROE is -1.66%, compared to DXR's ROE of +0.22%. Regarding short-term risk, MLSS is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check DXR's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
MLSS vs OMIC Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas OMIC's P/E ratio is -0.58. In terms of profitability, MLSS's ROE is -1.66%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, MLSS is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
MLSS vs IGAP Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas IGAP's P/E ratio is -10.52. In terms of profitability, MLSS's ROE is -1.66%, compared to IGAP's ROE of -0.86%. Regarding short-term risk, MLSS is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
MLSS vs NEPH Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, NEPH has a market cap of 38.6M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while NEPH trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas NEPH's P/E ratio is 50.86. In terms of profitability, MLSS's ROE is -1.66%, compared to NEPH's ROE of +0.08%. Regarding short-term risk, MLSS is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
MLSS vs POCI Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, POCI has a market cap of 33.8M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while POCI trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas POCI's P/E ratio is -6.07. In terms of profitability, MLSS's ROE is -1.66%, compared to POCI's ROE of -0.37%. Regarding short-term risk, MLSS is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check POCI's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
MLSS vs SDC Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas SDC's P/E ratio is -0.03. In terms of profitability, MLSS's ROE is -1.66%, compared to SDC's ROE of -1.96%. Regarding short-term risk, MLSS is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check SDC's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
MLSS vs HBIO Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, HBIO has a market cap of 27.3M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while HBIO trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas HBIO's P/E ratio is -16.81. In terms of profitability, MLSS's ROE is -1.66%, compared to HBIO's ROE of -0.73%. Regarding short-term risk, MLSS is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check HBIO's competition here
Invacare Corporation (NYSE: IVC)
MLSS vs IVC Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas IVC's P/E ratio is -0.79. In terms of profitability, MLSS's ROE is -1.66%, compared to IVC's ROE of -0.46%. Regarding short-term risk, MLSS is more volatile compared to IVC. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
MLSS vs RVP Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while RVP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas RVP's P/E ratio is -2.06. In terms of profitability, MLSS's ROE is -1.66%, compared to RVP's ROE of -0.08%. Regarding short-term risk, MLSS is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check RVP's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
MLSS vs ZJYL Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, ZJYL has a market cap of 16M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while ZJYL trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas ZJYL's P/E ratio is 12.75. In terms of profitability, MLSS's ROE is -1.66%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, MLSS is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check ZJYL's competition here
Femasys Inc. (NASDAQ: FEMY)
MLSS vs FEMY Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, FEMY has a market cap of 11.2M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while FEMY trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas FEMY's P/E ratio is -10.25. In terms of profitability, MLSS's ROE is -1.66%, compared to FEMY's ROE of -2.58%. Regarding short-term risk, MLSS is more volatile compared to FEMY. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
MLSS vs RGNT Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, RGNT has a market cap of 7.8M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while RGNT trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas RGNT's P/E ratio is -0.08. In terms of profitability, MLSS's ROE is -1.66%, compared to RGNT's ROE of N/A. Regarding short-term risk, MLSS is more volatile compared to RGNT. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check RGNT's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
MLSS vs NSTG Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas NSTG's P/E ratio is -0.03. In terms of profitability, MLSS's ROE is -1.66%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, MLSS is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check NSTG's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
MLSS vs NXGL Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, NXGL has a market cap of 4M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while NXGL trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas NXGL's P/E ratio is -1.13. In terms of profitability, MLSS's ROE is -1.66%, compared to NXGL's ROE of -0.70%. Regarding short-term risk, MLSS is more volatile compared to NXGL. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check NXGL's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
MLSS vs POAI Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas POAI's P/E ratio is -0.03. In terms of profitability, MLSS's ROE is -1.66%, compared to POAI's ROE of -107.05%. Regarding short-term risk, MLSS is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check POAI's competition here
Lucyd, Inc (NASDAQ: LUCY)
MLSS vs LUCY Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, LUCY has a market cap of 2.6M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while LUCY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas LUCY's P/E ratio is -0.39. In terms of profitability, MLSS's ROE is -1.66%, compared to LUCY's ROE of -0.83%. Regarding short-term risk, MLSS is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check LUCY's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
MLSS vs MHUA Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas MHUA's P/E ratio is 0.25. In terms of profitability, MLSS's ROE is -1.66%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, MLSS is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
MLSS vs NXGLW Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, NXGLW has a market cap of 1.8M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas NXGLW's P/E ratio is -0.06. In terms of profitability, MLSS's ROE is -1.66%, compared to NXGLW's ROE of -0.70%. Regarding short-term risk, MLSS is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check NXGLW's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
MLSS vs GMVD Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas GMVD's P/E ratio is -0.01. In terms of profitability, MLSS's ROE is -1.66%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, MLSS is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
MLSS vs GMVDW Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas GMVDW's P/E ratio is N/A. In terms of profitability, MLSS's ROE is -1.66%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, MLSS is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
MLSS vs AVGR Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas AVGR's P/E ratio is -0.05. In terms of profitability, MLSS's ROE is -1.66%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, MLSS is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
MLSS vs LUCYW Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas LUCYW's P/E ratio is -0.00. In terms of profitability, MLSS's ROE is -1.66%, compared to LUCYW's ROE of -0.83%. Regarding short-term risk, MLSS is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check LUCYW's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
MLSS vs GCTK Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, GCTK has a market cap of 165.2K. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while GCTK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas GCTK's P/E ratio is -0.01. In terms of profitability, MLSS's ROE is -1.66%, compared to GCTK's ROE of -5.82%. Regarding short-term risk, MLSS is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for MLSS.Check GCTK's competition here
Apria, Inc. (NASDAQ: APR)
MLSS vs APR Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, APR has a market cap of 0. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas APR's P/E ratio is 22.59. In terms of profitability, MLSS's ROE is -1.66%, compared to APR's ROE of +9.81%. Regarding short-term risk, MLSS is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
MLSS vs IIN Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, IIN has a market cap of 0. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas IIN's P/E ratio is 226.45. In terms of profitability, MLSS's ROE is -1.66%, compared to IIN's ROE of -0.00%. Regarding short-term risk, MLSS is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
MLSS vs ALOG Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas ALOG's P/E ratio is 40.93. In terms of profitability, MLSS's ROE is -1.66%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, MLSS is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
MLSS vs ATRS Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas ATRS's P/E ratio is 14.95. In terms of profitability, MLSS's ROE is -1.66%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, MLSS is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
MLSS vs IVTY Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas IVTY's P/E ratio is -3.80. In terms of profitability, MLSS's ROE is -1.66%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, MLSS is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check IVTY's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
MLSS vs HRC Comparison July 2026
Milestone Scientific Inc. (AMEX: MLSS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLSS stands at 34.5M. In comparison, HRC has a market cap of 0. Regarding current trading prices, MLSS is priced at $0.39 on the AMEX, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLSS currently has a P/E ratio of -6.50, whereas HRC's P/E ratio is 41.92. In terms of profitability, MLSS's ROE is -1.66%, compared to HRC's ROE of +0.14%. Regarding short-term risk, MLSS is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for MLSS.Check HRC's competition here